PL2827907T3 - Krótkie lipopeptydy przeciwdrobnoustrojowe - Google Patents
Krótkie lipopeptydy przeciwdrobnoustrojoweInfo
- Publication number
- PL2827907T3 PL2827907T3 PL13710751T PL13710751T PL2827907T3 PL 2827907 T3 PL2827907 T3 PL 2827907T3 PL 13710751 T PL13710751 T PL 13710751T PL 13710751 T PL13710751 T PL 13710751T PL 2827907 T3 PL2827907 T3 PL 2827907T3
- Authority
- PL
- Poland
- Prior art keywords
- antimicrobial lipopeptides
- short antimicrobial
- short
- lipopeptides
- antimicrobial
- Prior art date
Links
- 108010028921 Lipopeptides Proteins 0.000 title 1
- 230000000845 anti-microbial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Birds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613212P | 2012-03-20 | 2012-03-20 | |
| EP13710751.2A EP2827907B1 (en) | 2012-03-20 | 2013-03-07 | Short antimicrobial lipopeptides |
| PCT/US2013/029696 WO2013142088A1 (en) | 2012-03-20 | 2013-03-07 | Short antimicrobial lipopeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2827907T3 true PL2827907T3 (pl) | 2019-08-30 |
Family
ID=47901428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13710751T PL2827907T3 (pl) | 2012-03-20 | 2013-03-07 | Krótkie lipopeptydy przeciwdrobnoustrojowe |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9278994B2 (enExample) |
| EP (1) | EP2827907B1 (enExample) |
| JP (1) | JP6261560B2 (enExample) |
| KR (1) | KR20140136494A (enExample) |
| CN (2) | CN107080831A (enExample) |
| AR (1) | AR090439A1 (enExample) |
| AU (1) | AU2013235692B2 (enExample) |
| CA (1) | CA2864179A1 (enExample) |
| DK (1) | DK2827907T3 (enExample) |
| ES (1) | ES2729237T3 (enExample) |
| MX (1) | MX2014011290A (enExample) |
| MY (1) | MY163100A (enExample) |
| PL (1) | PL2827907T3 (enExample) |
| RU (2) | RU2627648C2 (enExample) |
| SG (2) | SG10201607784VA (enExample) |
| TW (1) | TWI541254B (enExample) |
| WO (1) | WO2013142088A1 (enExample) |
| ZA (1) | ZA201405950B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6906274B2 (ja) * | 2014-06-30 | 2021-07-21 | ロート製薬株式会社 | 外用組成物、眼科用組成物、抗菌剤、及び抗菌方法 |
| WO2016002767A1 (ja) * | 2014-06-30 | 2016-01-07 | ロート製薬株式会社 | 外用組成物 |
| US10660979B2 (en) * | 2015-08-26 | 2020-05-26 | The General Hospital Corporation | System and method for electrical control of bacteria |
| KR101855170B1 (ko) * | 2015-11-18 | 2018-05-08 | (주)노바셀테크놀로지 | 신규 항균 펩타이드 및 그의 용도 |
| CN109320585B (zh) * | 2018-09-06 | 2021-10-26 | 南方医科大学 | 一种具有专一性抗痤疮丙酸杆菌作用及抗炎作用的短脂肽 |
| CA3112268A1 (en) * | 2018-09-12 | 2020-03-19 | The Governing Council Of The University Of Toronto | Indole-oxadiazole compounds and their therapeutic use |
| CN111035764B (zh) * | 2018-10-14 | 2021-09-07 | 深圳市健元医药科技有限公司 | 一种治疗类风湿性关节炎的组合物及其制备方法 |
| CN110279844A (zh) * | 2019-01-31 | 2019-09-27 | 浙江星杭泰乐生物医药有限公司 | 人工合成抗菌肽在制备抑菌消炎祛痘化妆品或外用药物制剂中的应用及抑菌消炎祛痘组合物 |
| CN111303242B (zh) * | 2020-02-27 | 2022-04-26 | 广州领晟医疗科技有限公司 | 一种KdPT的修饰肽 |
| KR102163568B1 (ko) * | 2020-08-21 | 2020-10-07 | 주식회사 비드테크 | 지방산 항균펩타이드 및 이를 함유하는 항균 조성물 |
| MX2023003595A (es) * | 2020-09-29 | 2023-04-05 | Unilever Ip Holdings B V | Una composicion para el cuidado personal que comprende aminoacidos. |
| US11793746B2 (en) * | 2020-10-01 | 2023-10-24 | Chanda Zaveri | Intense skin hydration systems and methods |
| CN112679576B (zh) * | 2020-11-06 | 2022-09-20 | 黄石瀚海新材料科技有限公司 | 抗菌脂肽、抗菌脂肽水凝胶制备方法及其应用 |
| CN121471309B (zh) * | 2026-01-05 | 2026-07-07 | 中国科学院理化技术研究所 | 一种菌群友好型选择性抗真菌肽hri及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69230500D1 (de) * | 1991-10-28 | 2000-02-03 | Cytran Ltd | Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden. |
| JP3273314B2 (ja) * | 1998-08-12 | 2002-04-08 | 独立行政法人農業生物資源研究所 | 抗菌ペプチド及びこれを有効成分とする抗菌剤 |
| US6492326B1 (en) | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| DE10106852A1 (de) | 2001-02-14 | 2002-09-05 | T Luger | Entzündungshemmende Verbindungen |
| SE0300207D0 (sv) * | 2003-01-29 | 2003-01-29 | Karolinska Innovations Ab | New use and composition |
| US7671011B2 (en) * | 2003-06-19 | 2010-03-02 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| KR101045658B1 (ko) * | 2003-11-17 | 2011-07-01 | 쎄데르마 | 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물 |
| FR2870244B1 (fr) * | 2004-05-11 | 2011-01-07 | Centre Nat Rech Scient | Conjugues dipeptidiques antagonistes de l'alpha-msh |
| DE102004055541A1 (de) * | 2004-11-17 | 2006-05-18 | Henkel Kgaa | Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut |
| US20100215726A1 (en) * | 2009-02-25 | 2010-08-26 | Peter Thomas Roth | Compositions for Diminishing the Appearance of Wrinkles |
| CN102329375A (zh) * | 2011-09-30 | 2012-01-25 | 中国药科大学 | 一组末端酰胺化的抗菌肽 |
-
2013
- 2013-03-07 KR KR1020147028361A patent/KR20140136494A/ko not_active Ceased
- 2013-03-07 SG SG10201607784VA patent/SG10201607784VA/en unknown
- 2013-03-07 MY MYPI2014002316A patent/MY163100A/en unknown
- 2013-03-07 EP EP13710751.2A patent/EP2827907B1/en active Active
- 2013-03-07 PL PL13710751T patent/PL2827907T3/pl unknown
- 2013-03-07 CN CN201710009878.5A patent/CN107080831A/zh active Pending
- 2013-03-07 MX MX2014011290A patent/MX2014011290A/es unknown
- 2013-03-07 RU RU2014142038A patent/RU2627648C2/ru not_active IP Right Cessation
- 2013-03-07 WO PCT/US2013/029696 patent/WO2013142088A1/en not_active Ceased
- 2013-03-07 CA CA2864179A patent/CA2864179A1/en not_active Abandoned
- 2013-03-07 DK DK13710751.2T patent/DK2827907T3/da active
- 2013-03-07 AU AU2013235692A patent/AU2013235692B2/en not_active Ceased
- 2013-03-07 US US14/385,517 patent/US9278994B2/en active Active
- 2013-03-07 RU RU2017127273A patent/RU2017127273A/ru not_active Application Discontinuation
- 2013-03-07 CN CN201380014970.0A patent/CN104379177B/zh active Active
- 2013-03-07 ES ES13710751T patent/ES2729237T3/es active Active
- 2013-03-07 JP JP2015501713A patent/JP6261560B2/ja not_active Expired - Fee Related
- 2013-03-07 SG SG11201405244RA patent/SG11201405244RA/en unknown
- 2013-03-19 TW TW102109748A patent/TWI541254B/zh not_active IP Right Cessation
- 2013-03-20 AR ARP130100903A patent/AR090439A1/es unknown
-
2014
- 2014-08-13 ZA ZA2014/05950A patent/ZA201405950B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013235692B2 (en) | 2016-12-08 |
| AR090439A1 (es) | 2014-11-12 |
| JP2015512386A (ja) | 2015-04-27 |
| ES2729237T3 (es) | 2019-10-31 |
| TWI541254B (zh) | 2016-07-11 |
| TW201339176A (zh) | 2013-10-01 |
| CN107080831A (zh) | 2017-08-22 |
| CA2864179A1 (en) | 2013-09-26 |
| RU2627648C2 (ru) | 2017-08-09 |
| CN104379177B (zh) | 2017-07-04 |
| SG11201405244RA (en) | 2014-10-30 |
| KR20140136494A (ko) | 2014-11-28 |
| MY163100A (en) | 2017-08-04 |
| JP6261560B2 (ja) | 2018-01-17 |
| US20150080291A1 (en) | 2015-03-19 |
| SG10201607784VA (en) | 2016-11-29 |
| CN104379177A (zh) | 2015-02-25 |
| DK2827907T3 (da) | 2019-06-11 |
| AU2013235692A1 (en) | 2014-09-25 |
| EP2827907A1 (en) | 2015-01-28 |
| RU2014142038A (ru) | 2016-05-10 |
| EP2827907B1 (en) | 2019-03-06 |
| ZA201405950B (en) | 2017-08-30 |
| RU2017127273A (ru) | 2019-02-04 |
| WO2013142088A1 (en) | 2013-09-26 |
| HK1204453A1 (en) | 2015-11-20 |
| US9278994B2 (en) | 2016-03-08 |
| MX2014011290A (es) | 2014-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL239568A0 (en) | Antimicrobial preparations and their uses | |
| ZA201405950B (en) | Short antimicrobial lipopeptides | |
| IL228388A0 (en) | Antimicrobial agents | |
| SG11201504967TA (en) | Improved antimicrobial compositions | |
| GB201218813D0 (en) | Antimicrobial peptides | |
| PL2932850T3 (pl) | Kompozycja biobójcza | |
| GB201420527D0 (en) | Electrical-wire-protecting member | |
| EP2923577A4 (en) | ANTIMICROBIAL COMPOSITION | |
| ZA201406877B (en) | Suspoemulsion | |
| GB201903206D0 (en) | n | |
| ZA201406786B (en) | Anti-malarial agents | |
| EP2910004A4 (en) | LIMITATION OF MOVEMENT | |
| ZA201408094B (en) | Anti-malarial agents | |
| ZA201503372B (en) | Antimicrobial agents | |
| ZA201502275B (en) | Antibacterial compositions | |
| GB2518076B (en) | Electrical-wire-protecting member | |
| PL2833929T3 (pl) | Opatrunek przeciwdrobnoustrojowy | |
| GB2525994B (en) | Antimicrobial ophthalmic devices | |
| ZA201408903B (en) | Antimicrobial composition | |
| GB201217281D0 (en) | Disinfectant formulation - MS71 | |
| PL2633749T3 (pl) | Maszyna żniwna | |
| GB201211202D0 (en) | Antimicrobial compounds | |
| EP2875141A4 (en) | ANTIMICROBIAL AGENTS | |
| GB201211203D0 (en) | Antimicrobial compounds | |
| GB201212457D0 (en) | Smart-road-smart-smart-vehicle synergy |